Why Cancer biomarker Market Demand Is Rising Worldwide
The demand for the Cancer biomarker Market is increasing due to the global burden of cancer. Patients and healthcare providers are seeking faster, less invasive, and more reliable diagnostic solutions. Biomarkers offer a pathway to personalized treatment and improved survival rates.
Rising investments in cancer research and the commercialization of biomarker-based diagnostic kits are further accelerating market demand. Pharmaceutical R&D pipelines are increasingly dependent on biomarkers for targeted drug development.
Market Outlook: Valued at USD 15.9 billion in 2022, the cancer biomarker market is forecasted to reach USD 27.8 billion by 2030, achieving a 9.8% CAGR during 2023–2030.
1 vista